Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoma, Non-Small-Cell Lung × figitumumab × Clear all

Phase

Status

Completed 3 Terminated 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1

Interventions

Carboplatin 29 Pemetrexed 22 Cisplatin 19 Paclitaxel 17 Docetaxel 15 Radiotherapy 14 durvalumab 13 Nivolumab 13 Gemcitabine 13 pembrolizumab 12 Radiosurgery 12 Erlotinib Hydrochloride 8 Taxes 7 atezolizumab 6 Magnetic Resonance Spectroscopy 6 Drug Therapy 6 Cyclophosphamide 6 Bevacizumab 6 Gefitinib 5 130-nm albumin-bound paclitaxel 5 Platinum 4 sotorasib 3 Surveys and Questionnaires 3 Sirolimus 3 Ramucirumab 3 Polymerase Chain Reaction 3 Immunotherapy 3 Fulvestrant 3 Fluorodeoxyglucose F18 3 Etoposide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00907504 2014-06-17

ADVIGO1017

Pfizer

Phase 3 Withdrawn

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡